Vivos Therapeutics (VVOS) Common Equity (2019 - 2026)
Vivos Therapeutics' Common Equity came in at -$3.99 million for Q2 2026, compared with $4.58 million a year earlier.
Powered by 
Analysis
Vivos Therapeutics (VVOS) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Vivos Therapeutics' Common Equity was -$1.55 million.
- Going back by year, Common Equity was $7.95 million in FY2024, $411,000 in FY2023 (-91.4%), $4.8 million in FY2022 (-81.2%) and $25.54 million in FY2021 (+51.0%).
- The Q2 2026 figure represents the lowest quarterly Common Equity in data going back to Q4 2019.
- The fastest year-over-year change in Common Equity over five years came in Q1 2025 (growth of 657.2%), and the weakest in Q3 2023 (a decline of 99.5%).
- Business Quant data shows VVOS's Common Equity at -$1.27 million (Q1 2026), -$1.55 million (Q4 2025) and $2.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.42 Bn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 10.72 Bn |
| 10 | Vivos Therapeutics | 1.89 Mn | -7.32 Mn | 2.95 Mn | -3.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.99 Mn |
| Mar 31, 2026 | -1.27 Mn |
| Dec 31, 2025 | -1.55 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 4.58 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 7.95 Mn |
| Sep 30, 2024 | 7.67 Mn |
| Jun 30, 2024 | 6.35 Mn |
| Mar 31, 2024 | 582,000.00 |
| Dec 31, 2023 | 411,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 6.99 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Sep 30, 2022 | 9.86 Mn |
| Jun 30, 2022 | 14.84 Mn |
| Mar 31, 2022 | 21.04 Mn |
| Dec 31, 2021 | 25.54 Mn |
| Sep 30, 2021 | 32.47 Mn |
API Access
Vivos Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VVOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VVOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VVOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();